Kidney manifestations are observed in 50% of the patients, typically manifesting with multicystic kidney disease ... the principal metabolic pathways deregulated in Autosomal Dominant Polycystic ...

Real-world data supports tolvaptan use to slow kidney function decline in patients with autosomal dominant polycystic kidney disease (ADPKD).

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments.

Polycystic kidney disease causes about 5% of all kidney failure cases and occurs when a person develops multiple cysts in their kidneys. These can damage the kidneys if they become too big.

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments.

A team of geneticists from Rutgers University has made a discovery that could lead to new therapies for polycystic kidney disease (PKD), a common genetic disorder affecting over 12.4 million people ...

Hyperglycemia, or high blood sugar, is a significant risk factor for kidney damage in people with type 1 and type 2 diabetes, as are high blood pressure and obesity. While there isn’t a cure for ...

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments.

Before receiving a kidney transplant, patients with autosomal dominant polycystic kidney disease often undergo a nephrectomy. But there hasn’t been clear guidance on who’s a good candidate ...

They told me that my spleen would heal—but unrelated to the accident, based on the scans, they suspected that I might have polycystic kidney disease (PKD) and suggested that I consult a kidney ...